Researchers develop a small-molecule 'sunless tan' to guard against skin cancer
Researchers have designed a small-molecule SIK inhibitor capable of penetrating human skin, which could lead the way to a ‘sunless tan’ that has the potential to reduce the risk of skin cancer. The molecule, developed at Massachusetts General Hospital and the Dana-Farber Cancer Institute, bypasses the defective receptor that prevents many fair-skinned people from tanning and stimulates melanin production further down the line.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.